AU611540B2 - Peptides with pharmaceutical activity - Google Patents

Peptides with pharmaceutical activity Download PDF

Info

Publication number
AU611540B2
AU611540B2 AU31383/89A AU3138389A AU611540B2 AU 611540 B2 AU611540 B2 AU 611540B2 AU 31383/89 A AU31383/89 A AU 31383/89A AU 3138389 A AU3138389 A AU 3138389A AU 611540 B2 AU611540 B2 AU 611540B2
Authority
AU
Australia
Prior art keywords
hydroxy
group
amino
formula
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31383/89A
Other languages
English (en)
Other versions
AU3138389A (en
Inventor
Davide Della Bella
Angelo Carenzi
Dario Chiarino
Franco Pellacini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Original Assignee
Zambon Group SpA
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA, Zambon SpA filed Critical Zambon Group SpA
Publication of AU3138389A publication Critical patent/AU3138389A/en
Application granted granted Critical
Publication of AU611540B2 publication Critical patent/AU611540B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AU31383/89A 1988-03-16 1989-03-15 Peptides with pharmaceutical activity Ceased AU611540B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8819791A IT1216104B (it) 1988-03-16 1988-03-16 Peptidi ad attivita' farmaceutica.
IT19791/88 1988-03-16

Publications (2)

Publication Number Publication Date
AU3138389A AU3138389A (en) 1989-09-21
AU611540B2 true AU611540B2 (en) 1991-06-13

Family

ID=11161247

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31383/89A Ceased AU611540B2 (en) 1988-03-16 1989-03-15 Peptides with pharmaceutical activity

Country Status (12)

Country Link
US (1) US5145872A (de)
EP (1) EP0333000B1 (de)
JP (1) JPH024748A (de)
AT (1) ATE89549T1 (de)
AU (1) AU611540B2 (de)
CA (1) CA1331419C (de)
DE (1) DE68906572T2 (de)
ES (1) ES2054904T3 (de)
IE (1) IE890748L (de)
IL (1) IL89538A0 (de)
IT (1) IT1216104B (de)
ZA (1) ZA891783B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0715008B2 (ja) * 1989-07-04 1995-02-22 帝人株式会社 圧縮成形用組成物
ES2052454B1 (es) * 1992-12-31 1995-01-16 Zambon S A Dipeptidos y composiciones que los contienen con accion farmaceutica contra el envejecimiento.
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
EP0679153A4 (de) * 1993-01-14 1996-05-15 Magainin Pharma Endständig modifizierte aminosäuren und peptide.
US5455262A (en) * 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors
FR2770844A1 (fr) * 1997-11-10 1999-05-14 Inst Nat Sante Rech Med Inhibiteurs de toxines clostridiales et compositions pharmaceutiques les contenant
WO2001036404A1 (en) * 1999-11-19 2001-05-25 Smithkline Beecham Corporation Compounds and methods
DE102006042147A1 (de) * 2006-09-06 2008-03-27 Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik Hydrochloride von 3-Amino-2-hydroxycarbonsäureamiden

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3138489A (en) * 1988-03-16 1989-09-21 Zambon Group S.P.A. Peptides with pharmaceutical activity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029547A (en) * 1974-07-01 1977-06-14 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Biologically active substance, bestatin, and production thereof
US4052449A (en) * 1974-07-01 1977-10-04 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Biologically active substance, bestatin, and production thereof
ES486572A1 (es) * 1978-11-25 1980-09-16 Nippon Kayaku Kk Procedimiento para la fabricacion de acidos treo-3-amino-2- hidroxibutanoil amonoaceticos.
JPS5828867B2 (ja) * 1979-07-13 1983-06-18 財団法人 微生物化学研埋会 新テトラペプチド誘導体類
JPS5767516A (en) * 1980-09-24 1982-04-24 Microbial Chem Res Found Novel analgesic agent
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4599325A (en) * 1984-02-16 1986-07-08 G. D. Searle & Co. Substituted tyrosyl alanine dipeptide amides
DE3628650A1 (de) * 1986-03-12 1987-09-24 Bayer Ag Renininhibitoren, verfahren zur herstellung und ihre verwendung
US4942154A (en) * 1987-06-18 1990-07-17 Merck & Co., Inc. Steroidal glycolipids as host resistance stimulators against viral infection
US4883808A (en) * 1987-08-27 1989-11-28 American Biotechnology Company Condensation products of cyclic diketones and ascorbic acid as immunomodulatory agents
US4894392A (en) * 1987-08-27 1990-01-16 Merck & Co., Inc. Aminoalkyl naphthalenediols as host resistance enhancers
US4900547A (en) * 1987-10-23 1990-02-13 University Of British Columbia Method to immunize mammals against tumors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3138489A (en) * 1988-03-16 1989-09-21 Zambon Group S.P.A. Peptides with pharmaceutical activity

Also Published As

Publication number Publication date
DE68906572T2 (de) 1993-08-26
ES2054904T3 (es) 1994-08-16
IL89538A0 (en) 1989-09-10
IT1216104B (it) 1990-02-22
IE890748L (en) 1989-09-16
JPH024748A (ja) 1990-01-09
ATE89549T1 (de) 1993-06-15
EP0333000A2 (de) 1989-09-20
EP0333000A3 (en) 1990-11-28
ZA891783B (en) 1989-11-29
US5145872A (en) 1992-09-08
AU3138389A (en) 1989-09-21
DE68906572D1 (de) 1993-06-24
CA1331419C (en) 1994-08-09
IT8819791A0 (it) 1988-03-16
EP0333000B1 (de) 1993-05-19

Similar Documents

Publication Publication Date Title
AU673398B2 (en) Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
US4996358A (en) Hydroxylamine bearing amino acid derivatives as collagenase inhibitors
AU636713B2 (en) Inhibitors of nitric oxide biosynthesis
SK64993A3 (en) Hydroxamic acid derivatives, method of their preparation and medicaments with their content
GB2095682A (en) Compounds of the formula
JPH0346463B2 (de)
US5210266A (en) N-substituted mercaptopropanamide derivatives
CA2216151A1 (en) Reversible protease inhibitors
CA1322073C (en) Thiol-carboxylic acid derivatives
EP0253190B1 (de) Teilweise retro-invertierte Analoge des Tuftsin, Methode zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
KR20140014081A (ko) 아밀로이드 피브릴 형성과 관련된 증상 치료용 디펩티드 유사체
JP3911293B2 (ja) プロテアーゼを阻害するコハク酸誘導体
NO178541B (no) Farmakologisk virksomme hydrazinderivater
US5179125A (en) N-substituted mercaptopropanamide derivatives
AU611540B2 (en) Peptides with pharmaceutical activity
JPH0422907B2 (de)
CA2253590A1 (en) Inhibitors of the production of s-cd23 and the secretion of tnf
CA2251292A1 (en) N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
CA2197566A1 (en) New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects
DK152208B (da) Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
EP0341081B1 (de) Derivate von Aminsäuren
EP0322633A1 (de) Mercapto-acylaminosäure-Antihypertensiver
BR112014006600B1 (pt) Composto, composição farmacêutica contendo o referido composto, uso de um composto e processo para a sintetização de compostos
AU611269B2 (en) Peptides with pharmaceutical activity
DE3939747A1 (de) Renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln